Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Injection Pen Companies

Several pharmaceutical companies manufacture injection pens, which are devices designed for the convenient and accurate administration of injectable medications. These pens are commonly used for self-administration of various medications, including insulin for diabetes, growth hormones, and certain types of therapies. 

injection pen market

 


Latest Injection Pen Companies Updates:


Eli Lilly's launch of Trulicity Pen This glucagon-like peptide-1 (GLP-1) receptor agonist pen for diabetes management offers a pre-filled, single-dose option, simplifying use and potentially improving adherence.


Novo Nordisk's Xultoty pen advancements This company received FDA approval for a higher-dose Xultoty pen for adults with type 2 diabetes, combining insulin and GLP-1 therapy in a single pen for increased convenience.


Sanofi's Soliqua Flexpen approval This pre-mixed insulin and GLP-1 pen for type 2 diabetes management, with flexible dosing options, caters to individual patient needs and potentially improves treatment outcomes.


Owen Mumford's focus on smart pens This company continues to develop and refine its smart pen technologies, with features like blood glucose monitoring and real-time data communication, aiming to provide a more holistic diabetes management system.


List of Injection Pen Key companies in the market:



  • Novo Nordisk

  • Eli Lilly

  • Sanofi

  • Merck

  • Ypsomed

  • AstraZeneca

  • Hoffman-La Roche

  • Becton Dickinson and company


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.